Large-scale production of high-quality helper-dependent adenoviral vectors using adherent cells in cell factories

Human Gene Therapy

Volumn 21, Issue 1, 2010, Pages 120-126

  Suzuki, Masataka ^a   Cela, Racel ^a   Clarke, Christian ^a   Bertin, Terry K ^a   Mouriño, Susana ^a,b   Lee, Brendan ^a,c  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF NAVARRA   (Spain)

^c HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; CRE RECOMBINASE; HELPER DEPENDENT ADENOVIRUS VECTOR; UNCLASSIFIED DRUG;

ARTICLE; CELL ADHESION; CONTROLLED STUDY; CULTURE MEDIUM; DRUG CONTAMINATION; GENE REARRANGEMENT; HUMAN; HUMAN CELL; LOXP SITE; NONHUMAN; SUSPENSION CELL CULTURE; VIRUS GENOME; VIRUS INFECTIVITY; VIRUS PARTICLE;

ADENOVIRIDAE; BETA-GALACTOSIDASE; CELL ADHESION; CELL CULTURE TECHNIQUES; CELL LINE; GENETIC VECTORS; HELPER VIRUSES; HUMANS;

ADENOVIRIDAE;

EID: 74949114755     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.2009.096     Document Type: Article

References (18)

1. Barjot, C., Hartigan-O'Connor, D., Salvatori, G., Scott, J.M., and Chamberlain, J.S. (2002). Gutted adenoviral vector growth using E1=E2b=E3-deleted helper viruses. J. Gene Med. 4, 480-489.
2. Brown, B.D., Shi, C.X., Powell, S., Hurlbut, D., Graham, F.L., and Lillicrap, D. (2004). Helper-dependent adenoviral vectors mediate therapeutic factor VIII expression for several months with minimal accompanying toxicity in a canine model of severe hemophilia A. Blood 103, 804-810.
3. Brunetti-Pierri, N., Palmer, D.J., Beaudet, A.L., Carey, K.D., Finegold, M., and Ng, P. (2004). Acute toxicity after high-dose systemic injection of helper-dependent adenoviral vectors into nonhuman primates. Hum. Gene Ther. 15, 35-46.
4. Cerullo, V., Seiler, M.P., Mane, V., Cela, R., Clarke, C., Kaufman, R.J., Pipe, S.W., and Lee, B. (2007). Correction of murine hemophilia A and immunological differences of factor VIII variants delivered by helper-dependent adenoviral vectors. Mol. Ther. 15, 2080-2087.
5. Ehrhardt, A., Xu, H., Dillow, A.M., Bellinger, D.A., Nichols, T.C., and Kay, M.A. (2003). A gene-deleted adenoviral vector results in phenotypic correction of canine hemophilia B without liver toxicity or thrombocytopenia. Blood 102, 2403-2411.
6. Morral, N., O'Neal, W., Rice, K., Leland, M., Kaplan, J., Piedra, P.A., Zhou, H., Parks, R.J., Velji, R., Aguilar-Cordova, E., Wadsworth, S., Graham, F.L., Kochanek, S., Carey, K.D., and Beaudet, A.L. (1999). Administration of helper-dependent adenoviral vectors and sequential delivery of different vector serotype for long-term liver-directed gene transfer in baboons. Proc. Natl. Acad. Sci. U. S. A. 96, 12816-12821.
7. Ng, P., Beauchamp, C., Evelegh, C., Parks, R., and Graham, F.L. (2001). Development of a FLP=frt system for generating helper-dependent adenoviral vectors. Mol. Ther. 3, 809-815.
8. Ng, P., and Graham, F.L. (2002). Construction of first-generation adenoviral vectors. Methods Mol. Med. 69, 389-414.
9. Ng, P., Parks, R.J., and Graham, F.L. (2002). Preparation of helper-dependent adenoviral vectors. Methods Mol. Med. 69, 371-388.
10. Palmer, D., and Ng, P. (2003). Improved system for helper-dependent adenoviral vector production. Mol. Ther. 8, 846-852.
11. Palmer, D.J., and Ng, P. (2004). Physical and infectious titers of helper-dependent adenoviral vectors: a method of direct comparison to the adenovirus reference material. Mol. Ther. 10, 792-798.
12. Palmer, D.J., and Ng, P. (2005). Helper-dependent adenoviral vectors for gene therapy. Hum. Gene Ther. 16, 1-16.
13. Palmer, D.J., and Ng, P. (2008). Methods for the production of helper-dependent adenoviral vectors. Methods Mol. Biol. 433, 33-53.
14. Parks, R.J., Chen, L., Anton, M., Sankar, U., Rudnicki, M.A., and Graham, F.L. (1996). A helper-dependent adenovirus vector system: removal of helper virus by Cre-mediated excision of the viral packaging signal. Proc. Natl. Acad. Sci. U. S. A. 93, 13565-13570.
15. Sakhuja, K., Reddy, P.S., Ganesh, S., Cantaniag, F., Pattison, S., Limbach, P., Kayda, D.B., Kadan, M.J., Kaleko, M., and Connelly, S. (2003). Optimization of the generation and propagation of gutless adenoviral vectors. Hum. Gene Ther. 14, 243-254.
16. Schnell, M.A., Zhang, Y., Tazelaar, J., Gao, G.P., Yu, Q.C., Qian, R., Chen, S.J., Varnavski, A.N., Leclair, C., Raper, S.E., and Wilson, J.M. (2001). Activation of innate immunity in nonhu-man primates following intraportal administration of adeno-viral vectors. Mol. Ther. 3, 708-722.
17. Zhang, Y., Chirmule, N., Gao, G.P., Qian, R., Croyle, M., Joshi, B., Tazelaar, J., and Wilson, J.M. (2001). Acute cyto-kine response to systemic adenoviral vectors in mice is mediated by dendritic cells and macrophages. Mol. Ther. 3, 697-707.
18. Zhou, H., Zhao, T., Pastore, L., Nageh, M., Zheng, W., Rao, X.M., and Beaudet, A.L. (2001). A Cre-expressing cell line and an E1=E2a double-deleted virus for preparation of helper-dependent adenovirus vector. Mol. Ther. 3, 613-622.